Children’s National Medical Center

Stratasys opens enrollment is 3DHEART pediatric clinical study

Wednesday, March 8, 2017

Stratasys, a 3D printing and additive manufacturing solutions company, announced enrollment is now open for 3DHEART, an investigator initiated trial. 3DHEART, which stands for 3DHearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3D printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.

[Read More]